Source: Pharmabiz

Sekisui: SEKISUI Diagnostics launches Metrix COVID/Flu Test for use at the pointofcare and home

SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix COVID/Flu Test, the second assay on the Metrix Molecular Platform for use at the point─of─care and in the

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Robert Schruender's photo - President & CEO of Sekisui

President & CEO

Robert Schruender

CEO Approval Rating

87/100

Read more